SEC Contract Filing

Filing Date: 2016-05-23

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>cosm_101.htm
<DESCRIPTION>MEMORANDUM OF UNDERSTANDING
<TEXT>
<html><head><title>cosm_101.htm</title><!--Document Created by EDGARMaster--></head><BODY style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN; MARGIN: 0px 7%" scroll="yes"><p style="MARGIN: 0px" align="right"><b>EXHIBIT 10.1</b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" align="center"><b><u><font size="2">Memorandum of Understanding (MOU)</font></u></b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"><font size="2">This Memorandum of Understanding (MOU) is by and between: </font></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"><font size="2">a) Cosmos Holdings Inc. (hereinafter" Cosmos"), a company incorporated in Nevada, whose shares are publicly traded on the U.S. OTCMarkets under the ticker: COSM, and </font></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"><font size="2">b)</font><font size="2"> DOC Pharma SA</font><font size="2">, based in Ag. Georgiou 5, TK57001, Thessaloniki, Greece, </font><font size="2">agree on the present MOU that comes into force on the 20<sup>th</sup> of May 2016, and expires on the 31<sup>st</sup> of December 2016.</font></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"><font size="2">DOC Pharma SA is an ISO certified and licensed GDP (Good Distribution Practices) whole sales of pharmaceutical products. It is the owner of numerous licenses of generic medicines and uses its own network of pharmaceutical sales representatives to communicate its products with doctors. The company also trades prototype medicines, food supplements, and cosmetics. </font></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"><b><font size="2">Purpose of this MOU:</font></b></p><p style="MARGIN: 0px"><strong>&nbsp;</strong><font size="2"><br>This MOU is a preliminary agreement whose purpose is to conclude to a final agreement in which Cosmos will acquire DOC Pharma with cash and shares of Cosmos stock the amount of which will be determined before a definitive agreement is signed (the "Transaction"). The shares will be issued to the owner of DOC Pharma according to exchange agreements that will follow. Cosmos' principal stockholder, CEO and a director, Grigorios Siokas, also controls DOC Pharma, and this will be a related party transaction. The process of share and assets exchange is described below. </font></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"><font size="2">Both parties will proceed to a final agreement only if all conditions will be agreed to by both parties. If both parties do not agree on all conditions there will be no definitive contracts and no obligations by any party. </font></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"><font size="2">Execution of a definitive agreement and subsequent closing is subject to, among other things, tax and legal considerations and satisfactory completion of due diligence.</font></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"><font size="2">Both parties will use their best efforts in order to sign a definitive agreement, but are under no obligation to do so and may not do so for any reason in their sole and absolute discretion. </font></p><p style="MARGIN: 0px">&nbsp;</p><font size="2">During the period that this MOU is valid Cosmos and DOC Pharma will focus their efforts to complete the Transaction. <p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"><table id="pagebreakeb5da087-69ba-47e9-bf46-f8ed876583ba" class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" border="0"> <tr><td class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center">1</td></tr><tr></tr><tr><td><div style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div></td></tr><tr><td>&nbsp;</td></tr></table></p>&nbsp;</font>&nbsp; <p style="MARGIN: 0px"><font size="2">From now on, the Parties understand and agree as follows:<br><b>&nbsp;</b></font></p><p style="MARGIN: 0px"><font size="2"><b>Agreements</b><br><b>&nbsp;</b></font></p><p style="MARGIN: 0px"><font size="2"><b>1) Summary.</b> DOC Pharma will transfer its existing pharmaceutical business to Cosmos. Cosmos will issue shares to DOC Pharma's owners for the acquisition of DOC Pharma. Cosmos will conduct data sharing, proper auditing, and legal due diligence to DOC Pharma in order to complete the transaction.<br>&nbsp;<br><b>2)</b> Negotiation period and procedures: The parties agree to make preparations for the definitive agreements promptly (and to the best knowledge and conscious not to endanger any business as described below):</font></p><p style="MARGIN: 0px">&nbsp;&nbsp;</p><p style="MARGIN: 0px"><b><font size="2">a)</font></b><font size="2"> The parties will be working together in order to create the appropriate conditions for a final closing by the 31<sup>st</sup> of December 2016. This date will be the last valid day of this MOU.<br><b>&nbsp;</b></font></p><p style="MARGIN: 0px"><font size="2"><b>b)</b> The Parties shall jointly operate, meet, and exchange information with the intention of completing the transaction safely and within determined timeframes.<br><b>&nbsp;</b></font></p><p style="MARGIN: 0px"><font size="2"><b>c)</b> Specifically, the parties agree, to discuss and conclude on</font></p><p style="MARGIN: 0px">&nbsp;</p><font size="2"><p style="MARGIN: 0px"><table style="FONT: 10pt times new roman" width="100%" border="0"> <tr><td valign="top" width="45"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="top" width="45"><p style="MARGIN: 0px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol">&#183;</font></p></td><td><p style="MARGIN: 0px" align="justify">The proper and timely auditing of DOC Pharma</p></td></tr><tr><td valign="top" width="45"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="top" width="45"><p style="MARGIN: 0px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol">&#183;</fo